For many years, cloned ponies have excelled in the prestigious equestrian sport of polo, and the sport has now taken a ...

Zacks Research decreased their Q1 2025 EPS estimates for CRISPR Therapeutics in a report issued on Wednesday, February 5th. Zacks Research analyst R. Department now anticipates that the company will ...

Scientists in the polo-obsessed nation have produced world's first genetically edited horses, designed to outrun champion ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Biohacking has moved from niche experiments to a global movement reshaping how we think about human potential. With ...

A Massachusetts man suffering from end-stage kidney disease has become the second living person to receive a genetically modified pig kidney transplant, marking a major milestone in the field of ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

KBC Group NV grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 71.4% during the 4th quarter, Holdings Channel reports. The firm owned 2,942 shares of the company’s stock after ...